Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02707588
Brief Title: Tolerance and Efficacy of Pembrolizumab or Cetuximab Combined With RT in Patients With Locally Advanced HNSCC (PembroRad)

First Submitted : February 29, 2016
First Submitted that Met QC Criteria : March 8, 2016
First Posted : March 14, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : April 8, 2021
Last Update Posted : April 9, 2021